Consensus Enovis Corporation

Stocks

ENOV

US1940145022

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 08:52:17 01/10/2026 pm IST			5-day change	1st Jan Change
17.84 ^USD	-2.33%		-2.35%	-33.03%

01/09	Top Midday Decliners	MT
01/09	BMO Capital Adjusts Enovis Price Target to $27 From $30, Maintains Outperform Rating	MT

Evolution of the Average Target: Enovis Corporation

Evolution of the Target Price: Enovis Corporation

Changes in Analyst Recommendations: Enovis Corporation

6373359ce97cc801441deb505c.uaB7T5VntetygBD0ipUaHdFusCFoi83vnIhGPZ1X_hc.zcNPI_Ip-7o_5k-Qy-NtSb4-gUpdw7re7-Y0futiqXrg6Ewe8QnjggbGWQ~d1dc09d9ea27d89be2d4ea489ef3990d

Analysts' recommendations: Enovis Corporation

01/09	BMO Capital Adjusts Enovis Price Target to $27 From $30, Maintains Outperform Rating	MT
28/07	UBS Adjusts Price Target on Enovis to $51 From $50, Maintains Buy Rating	MT
09/07	BMO Capital Initiates Enovis at Outperform With $29 Price Target	MT
27/02	Needham Raises Price Target on Enovis to $52 From $49, Keeps Buy Rating	MT
06/01	BTIG Initiates Enovis at Buy With $41 Price Target	MT
08/25/08	Needham Cuts Price Target on Enovis to $49 From $57, Keeps Buy Rating	MT
08/25/08	UBS Adjusts Enovis Price Target to $57 From $65, Maintains Buy Rating	MT
12/25/12	UBS Adjusts Price Target on Enovis to $65 From $75, Maintains Buy Rating	MT
03/24/03	JMP Securities Initiates Enovis at Outperform With $62 Price Target	MT
08/24/08	Needham Adjusts Price Target on Enovis to $65 From $82, Maintains Buy Rating	MT
13/24/13	JPMorgan Initiates Enovis at Neutral With $53 Price Target	MT
23/24/23	Canaccord Genuity Ups Price Target on Enovis to $75 From $73, Maintains Buy Rating	MT
23/24/23	Needham Raises Price Target on Enovis to $82 From $73, Maintains Buy Rating	MT
13/24/13	Stephens Initiates Enovis With Overweight Rating, $72 Price Target	MT
22/24/22	UBS Initiates Coverage on Enovis With Buy Rating, $75 Price Target	MT
03/24/03	William Blair Initiates Enovis at Outperform Rating	MT
20/23/20	Canaccord Genuity Adjusts Enovis Price Target to $71 From $65, Maintains Buy Rating	MT
15/23/15	Needham Adjusts Price Target on Enovis to $70 From $62, Keeps Buy Rating	MT
04/23/04	Baird Adjusts Price Target on Enovis to $70 From $67, Maintains Outperform Rating	MT
26/23/26	Needham Initiates Enovis With Buy Rating, $70 Price Target	MT
12/23/12	Wells Fargo Upgrades Enovis to Overweight Rating From Equal Weight, Adjusts Price Target to $67 From $55	MT
24/23/24	Baird Adjusts Enovis Price Target to $64 From $68, Maintains Outperform Rating	MT
03/22/03	Baird Adjusts Enovis' Price Target to $68 From $73, Keeps Outperform Rating	MT
26/22/26	Wells Fargo Lowers Enovis' Price Target to $53 From $60, Keeps Equalweight Rating	MT
12/22/12	Jefferies Initiates Enovis at Buy with $60 Price Target	MT

More recommendations

Medical Devices & Implants

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ENOVIS CORPORATION					+109.82%
	ABBOTT LABORATORIES					+21.69%
	MEDTRONIC PLC					+21.49%
	STRYKER CORPORATION					+33.56%
	ESSILORLUXOTTICA					+59.76%
	CENCORA, INC.					+22.98%
	BECTON, DICKINSON AND COMPANY					+9.31%
	HOYA CORPORATION					+28.07%
	IDEXX LABORATORIES, INC.					+34.31%
	DEXCOM, INC.					+9.49%
	Average					+35.05%
	Weighted average by Cap.					+27.64%